By rray, 3 June, 2024 Use standardized assessments to evaluate and follow sx over time 2 nbsp nbsp Montreal Cognitive Assessment MoCA nbsp nbsp Mini Mental Status Examination MMSE nbsp nbsp Compass 31 for dysautonomia nbsp nbsp Neurobehavioral Symptom Inventory
By rray, 3 June, 2024 PMHx med review esp antihistamines anticholinergics antidepressant anxiolytic muscle relaxants that may contribute to neuro sx 1 COVID severity hospitalization2 e g post ICU syndrome
By rray, 3 June, 2024 If HA r o secondary causes by hx e g systemic sx hx of CA HIV immunosuppression TB neuro s sx thunderclap onset age 50 positional precipitated by Valsalva hx new onset in pregnancy 1
By rray, 3 June, 2024 Sx quality Review predisposing comorbidities prior neuro sx time course triggers impact on QOL etc Assess current vs pre COVID functional status 2 Assess for current prior EtOH substance use diet exercise physical and cognitive activity social determinant
By rray, 3 June, 2024 Red flag sx sudden progressive weakness sudden progressive sensory changes unexplained pathologic reflexes spasticity in setting of weakness urinary or bowel incontinence retention syncope transient LOC acute neuropsych sx psychosis HA that is positional
By rray, 3 June, 2024 Neuro sequelae are common up to 10 of critically ill w COVID have CN involvement HA paresthesias neuropathies neuropathic pain occur even in pts w mild asymptomatic initial infection Post COVID cognitive deficit dementia psychotic d o and epilepsy or seiz
By rray, 3 June, 2024 Monitor comorbidities that may impact sx optimize sleep nutrition stress reduction